Current Issue

View Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3

Robert Dream, Managing Director, HDR Company LLC

Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...

Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...

Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...

Lifetime Study for JSR Amsphere A3 – Protein A Resin

JSR Life Sciences

Featured Articles

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)

Pall Corporation

Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer

Bristol Myers Squibb

Single-Use-Systems: Leachable Study Design for Single-Use Components

Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb

View All Featured Articles

Headline News

FDA approves Johnson & Johnson’s IMAAVY as the first treatment ever cleared for warm autoimmune hemolytic anemia, marking a major step forward for patients

Novartis presents cardiovascular data at ESC Congress 2026, reinforcing its position in heart health and highlighting progress on next-generation therapies

FDA approves Regeneron’s Pasatru the first treatment shown to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in a placebo-controlled trial for adults with fibrodysplasia ossificans progressiva

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities

Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC and Mark Bumiller, Technology Manager at Entegris, Inc
21st May 2020

The Disposable Facility and Single-Use Technology – a Solution or a Revolution? Sponsored by PALL

Presented by Dr Joachim Walter, Consultant at Walter Biotech Consultancy and Jerold Martin Sr. Vice President, Global Scientific Affairs for Pall Life Sciences
18th September 2013

Orthogonal Measures of Lentiviral Particle Attributes Using DLS, NTA, and Micro Flow Cytometry

Presented by Jim Richardson, Senior Director, Analytical Development at Interius Biotherapeutics and Kevin Lance, PhD, Director of Analytics Marketing at Unchained Labs
16th February 2023

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos